Psychemedics Corporation - PMD

About Gravity Analytica
Recent News
- 04.24.2025 - The Hidden Dangers of Delta-8 and Delta-9 in Safety-Sensitive Jobs: A Growing Concern in the Trucking Industry
- 04.10.2025 - Why Faculty Drug Testing Is Key to Ensuring Campus Safety
- 03.13.2025 - The Evolving Role of Drug Testing in a Post-Pandemic Workforce
- 03.04.2025 - 5 Signs Substance Abuse May Be Affecting Your Workforce
- 03.03.2025 - Psychemedics Launches Groundbreaking Quartile Reporting for Enhanced Drug Testing Insights
- 02.27.2025 - How Auto Insurance Providers Can Promote Safer Roads Through Drug-Free Driving Initiatives
- 02.06.2025 - Party Culture and Substance Use: How Schools Can Respond
- 01.30.2025 - Marijuana Legalization: What Employers Need to Know in 2025
- 01.30.2025 - Marijuana Legalization: What Employers Need to Know in 2025
- 01.23.2025 - Substance Abuse Trends to Watch in the Workforce This Year
Recent Filings
- 03.24.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
- 03.19.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
- 03.19.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
- 03.19.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
- 03.19.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
- 03.19.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
- 03.19.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
- 03.19.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments